The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination-Reference-Cited by-同舟云学术

The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination

Published:2020-02 Issue: Volume:174 Page:104703
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Clarke Elizabeth C.,Bradfute Steven B.

Funder

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference152 articles.

1. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function;Adachi;Immunity,1998

2. Cutting edge: CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion;Aichele;J. Immunol.,2006

3. Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus;Andersson;J. Virol.,2004

4. Crimean‐Congo hemorrhagic fever virus delays activation of the innate immune response;Andersson;J. Med. Virol.,2008

5. Type I interferon inhibits Crimean‐Congo hemorrhagic fever virus in human target cells;Andersson;J. Med. Virol.,2006

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation;PLOS Neglected Tropical Diseases;2024-08-19

2. Knowledge mapping of severe fever with thrombocytopenia syndrome: a bibliometric analysis;Frontiers in Microbiology;2024-07-30

3. Effects of the commensal microbiota on spleen and mesenteric lymph node immune function: investigation in a germ-free piglet model;Frontiers in Microbiology;2024-06-12

4. YF17D‐based vaccines – standing on the shoulders of a giant;European Journal of Immunology;2024-04-03

5. The Rift Valley fever (RVF) vaccine candidate 40Fp8 shows an extreme attenuation in IFNARKO mice following intranasal inoculation;2024-02-22